Jun 04, 2020
FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
May 07, 2020
Antibiotics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class ; Action Mechanism, and Geography
May 06, 2020
Antabio Receives QIDP Designation From the U.S. FDA for the Development of MEM-ANT3310, a Novel Broad-Spectrum Combination Therapy Targeting WHO's Priority Pathogens
Oct 22, 2019
Qpex Biopharma and Brii Biosciences Enter Into a Strategic Collaboration to Develop and Commercialize Antibiotics for Drug-Resistant Infections in China
Sep 25, 2019
Qpex Biopharma to Present its Anti-infective Portfolio at IDWeek 2019
Sep 10, 2019
Selux Diagnostics Selected to Lead IDWeek 2019 Panel Presentation, Poster Session
Aug 21, 2019
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34.17 Bn, Globally, by 2028 at 2.3% CAGR: Allied Market Research
Jul 24, 2019
Cipla USA Furthers AMR Stewardship With Acquisition of Key Anti-infective ZEMDRI(TM) (IV Plazomicin)
Jun 13, 2019
Qpex Biopharma to Provide First Public Presentations of Preclinical Data on the Novel Ultra-Broad-Spectrum Beta-lactamase Inhibitor QPX7728 for IV and Oral Products at 2019 ASM Microbe Meeting
May 16, 2019
GenePOC Obtains FDA Clearance for its GenePOC(TM) Carba Test in the US
Apr 16, 2019
FIU scientists discover new arsenic-based broad-spectrum antibiotic
Apr 01, 2019
Geom Therapeutics To Present Data From Antibiotic Drug Development Programs At ECCMID
Mar 18, 2019
Allergan Announces FDA Approval of AVYCAZ® (ceftazidime and avibactam) for Pediatric Patients
Jan 03, 2019
VenatoRx Pharmaceuticals Joins Antimicrobials Working Group
Nov 20, 2018
Allergan Announces FDA Acceptance of Supplemental New Drug Application for AVYCAZ® (ceftazidime and avibactam)
Nov 13, 2018
New Diagnostic Test Helps Hospitals More Quickly Identify and Treat Emerging Antibiotic-Resistant Bacteria
Oct 30, 2018
Antibiotics Market to Reach $50.37 Bn, Globally, by 2025 at 2.1% CAGR, Says Allied Market Research
Jun 01, 2018
Successful USFDA inspection of Asymchem Fuxin 1 carbapenem manufacturing facility
May 30, 2018
Geom Therapeutics To Present Data From Antibiotic Drug Development Programs At ASM Microbe
May 24, 2018
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance